Discover groundbreaking updates in lymphoma and CLL treatments, including innovative therapies and promising trial results from Dr Krish Patel.
Krish Patel, MD
Krish Patel, MD, is a hematologist and medical oncologist at SCRI Oncology Partners and director of lymphoma research at the Sarah Cannon Research Institute in Nashville, Tennessee.
Articles by Krish Patel, MD
Central Screening revolutionizes clinical trial enrollment by integrating technology and expertise, streamlining patient matching for targeted cancer therapies.
Krish Patel, MD, discusses the areas of research he finds particularly interesting for the treatment of patients with mantle cell lymphoma.
Kris Patel, MD, discusses the real-world data for treatment with ibrutinib in patients with relapsed/refractory mantle cell lymphoma as compared to clinical trials.
Latest Updated Articles
Real-World Data for Ibrutinib in Relapsed/​Refractory MCLPublished: January 15th 2019 | Updated:
Expert Highlights Areas of Research in MCLPublished: February 11th 2019 | Updated: